查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526830

2024 年脊椎生技藥品全球市場報告

Spine Biologics Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

脊椎生技藥品市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以5.4%的複合年成長率成長至29.1億美元。預測期內的成長將由技術創新、再生醫學的更多採用、研發投資的增加、肥胖和久坐生活方式的流行、新興市場的醫療保健覆蓋範圍擴大、有利的監管核准以及行業聯盟推動。和合作夥伴關係。這段時期預計的主要趨勢包括新型再生療法的出現、人工智慧在治療計劃中的整合、個人化醫療方法的擴展、客製化植入的3D列印的採用以及增強組織再生的生物工程。

道路事故發生率的增加可能會在短期內推動脊椎生物製藥市場的成長。交通事故被定義為公共道路上涉及一輛或多輛車輛的意外事件，導致嚴重的脊髓損傷，需要先進的醫療干預以進行有效的治療和康復。在全球範圍內，由於多種因素，包括駕駛分心、交通量增加、道路基礎設施不足以及酒精和藥物引起的損傷等，交通事故呈上升趨勢。脊椎生物製藥透過促進脊椎融合、加速癒合、降低手術風險、改善疼痛管理和最大限度地減少翻修手術的需要，在改善患者預後方面發揮重要作用。例如，根據美國公路交通安全管理局的資料，光是在美國，去年就有 42,915 人死於機動車事故，比 2020 年記錄的 38,824 人增加了 10.5%。因此，道路事故數量的增加正在推動脊椎生物製藥市場的擴張。

脊椎生物製藥市場的領導者正專注於開發合成生物活性骨移植物等先進產品，以更好地滿足患者需求並保持市場競爭力。合成生物活性骨移植物是脊椎生技藥品，旨在支持和增強脊椎融合手術中的骨骼生長和癒合。例如，美國脊椎和整形外科公司 Orthofix Medical Inc. 於 2022 年 2 月宣布推出 Opus BA。 Opus BA 有油灰和條狀形式，可作為骨骼生長的支架，並被吸收以取代天然骨骼。 Opus BA 可以自體骨髓或生理食鹽水進行自體移植，其骨傳導基質由碳酸磷灰石骨礦物質、生物活性玻璃和 1 型膠原蛋白組成，可促進骨生長和吸收。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球脊椎生技藥品市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球脊椎生技藥品市場表現：規模與成長，2018-2023
  • 全球脊椎生技藥品市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球脊椎生技藥品市場：按產品、性能和預測，2018-2023、2023-2028、2033
  • 同種異體骨移植
  • 骨移植替代品
  • 富含血小板的血漿
  • 骨髓抽吸治療
  • 全球脊椎生技藥品市場：依手術類型分類的表現與預測，2018-2023、2023-2028、2033
  • 前路頸椎間盤切除術融合術（ACDF）
  • 後側椎間融合術（PLIF）
  • 椎間椎間融合(TLIF)
  • 前路腰椎融合術（ALIF）
  • 側向腰椎椎間融合(LLIF)
  • 其他手術類型
  • 全球脊椎生技藥品市場：按應用、性能和預測，2018-2023、2023-2028、2033
  • 脊椎融合手術
  • 脊柱畸形癒合和骨折的修復
  • 退化性椎間盤疾病的治療
  • 其他用途
  • 全球脊椎生技藥品市場：最終使用者的表現與預測，2018-2023、2023-2028、2033
  • 醫院
  • 脊椎外科中心
  • 整形外科診所
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球脊椎生技藥品市場：按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球脊椎生技藥品市場：依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 脊椎生技藥品市場：競爭格局
  • 脊椎生技藥品市場：公司簡介
    • Johnson & Johnson Services Inc.
    • Medtronic PLC
    • Stryker Corporation
    • Baxter International Inc.
    • B. Braun Melsungen AG

第31章 其他重大及創新企業

  • Zimmer Biomet Holdings Inc.
  • Arthrex Inc.
  • Integra LifeSciences Corporation
  • Bone Biologics Corp.
  • InVivo Therapeutics Corp.
  • RTI Surgical Inc.
  • Paragon 28 Inc.
  • LifeNet Health Inc.
  • Xtant Medical Holdings Inc.
  • Kuros Biosciences AG
  • CoreLink LLC
  • Spinal Elements Inc.
  • Life Spine Inc.
  • Innovasis Inc.
  • Camber Spine Technologies LLC

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18479

Spine biologics, also referred to as spinal biologics, encompass biologically derived materials employed in the treatment of spinal conditions and injuries. These materials are utilized to stimulate bone formation, accelerate healing, and enhance the outcomes of spine surgery, particularly spinal fusion procedures. They encompass a variety of products, including bone grafts, growth factors, cell-based therapies, and biological scaffolds.

The primary products within spine biologics include bone allografts, bone graft substitutes, platelet-rich plasma, and bone marrow aspirate therapy. Bone allografts are grafts sourced from donors rather than from the patient's own body. Spine biologics find application across various types of surgeries, including anterior cervical discectomy and fusion (ACDF), posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and others. These products are utilized for diverse applications such as spinal fusion, treatment of spinal non-union and fractures, management of degenerative disc disease, among others. They are employed by various end users including hospitals, spinal surgery centers, orthopedic clinics, and others.

The spine biologics market research report is one of a series of new reports from The Business Research Company that provides spine biologics market statistics, including spine biologics industry global market size, regional shares, competitors with a spine biologics market share, detailed spine biologics market segments, market trends and opportunities, and any further data you may need to thrive in the spine biologics industry. This spine biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spine biologics market size has grown strongly in recent years. It will grow from $2.24 billion in 2023 to $2.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth observed in the historical period can be attributed to several factors, including advancements in biotechnology, an aging population, a high incidence of spinal disorders, increased preference for minimally invasive procedures, heightened awareness about spine health, improvements in diagnostic techniques, and enhanced healthcare infrastructure.

The spine biologics market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The projected growth in the forecast period is expected to be driven by technological innovations, increasing adoption of regenerative medicine, rising investment in research and development, growing prevalence of obesity and sedentary lifestyles, expanding healthcare access in emerging markets, favorable regulatory approvals, and increasing collaborations and partnerships within the industry. Significant trends anticipated for this period encompass the emergence of novel regenerative therapies, integration of artificial intelligence in treatment planning, expansion of personalized medicine approaches, adoption of 3D printing for customized implants, and the development of bioengineered scaffolds for enhanced tissue regeneration.

The increasing incidence of road accidents is poised to drive the growth of the spinal biologics market in the foreseeable future. Road accidents, defined as unintended events involving one or more vehicles on public roads resulting in severe spinal injuries, necessitate advanced medical interventions for effective treatment and recovery. Globally, road accidents are on the rise due to various factors, including distracted driving, higher traffic volumes, inadequate road infrastructure, and impairment from alcohol and drugs. Spinal biologics play a crucial role in enhancing patient outcomes by promoting spinal fusion, accelerating healing, reducing surgical risks, improving pain management, and minimizing the need for revision operations. For example, data from the National Highway Traffic Safety Administration reveals that in the US alone, an estimated 42,915 individuals lost their lives in motor vehicle traffic crashes last year, representing a 10.5% increase from the 38,824 fatalities recorded in 2020. Hence, the escalating number of road accidents is fueling the expansion of the spinal biologics market.

Leading companies in the spinal biologics market are focusing on developing advanced products, such as synthetic bioactive bone grafts, to better cater to patient needs and maintain a competitive edge in the market. Synthetic bioactive bone grafts are artificial spine biologics engineered to support and enhance bone growth and healing in spinal fusion surgeries. For instance, Orthofix Medical Inc., a US-based spine and orthopedics company, introduced Opus BA in February 2022. Opus BA, available in putty and strip forms, serves as a scaffold for bone growth, which is reabsorbed and replaced by natural bone. It can be hydrated with autogenous bone marrow or autografted with saline and features an osteoconductive matrix comprising carbonate apatite bone mineral, bioactive glass, and Type 1 collagen, facilitating bone growth and resorption.

In August 2023, Xtant Medical, a US-based medical technology company, acquired specific assets and liabilities of domestic and international biologics and spinal fixation products from Surgalign Holdings Inc. for an undisclosed sum. This strategic acquisition is poised to bolster Xtant Medical's product portfolio and market presence in the orthopedic and spine surgery sectors, leveraging the combined capabilities of both entities. Surgalign Holdings Inc. is a US-based medical technology company specializing in spine biologics and spinal fixation products.

Major companies operating in the spine biologics market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC , Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc, Aziyo Biologics, Amedica Corporation

North America was the largest region in the spine biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spine biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The spine biologics market consists of sales of bone morphogenetic proteins, synthetic bone grafts, and spine fusion systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spine Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spine biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spine biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spine biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Bone Allografts; Bone Graft Substitute; Platelet Rich Plasma; Bone Marrow Aspirate Therapy
  • 2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF); Posterior Lumbar Interbody Fusion (PLIF); Transforaminal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF); Other Surgery Types
  • 3) By Application: Spinal Fusion; Spinal Non-Union And Fracture Repair; Degenerative Disc Disease Treatment; Other Applications
  • 4) By End User: Hospitals; Spinal Surgery Centers; Orthopedic Clinics; Other End Users
  • Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic PLC; Stryker Corporation; Baxter International Inc.; B. Braun Melsungen AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spine Biologics Market Characteristics

3. Spine Biologics Market Trends And Strategies

4. Spine Biologics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Spine Biologics Market Size and Growth

  • 5.1. Global Spine Biologics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Spine Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Spine Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Spine Biologics Market Segmentation

  • 6.1. Global Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bone Allografts
  • Bone Graft Substitute
  • Platelet Rich Plasma
  • Bone Marrow Aspirate Therapy
  • 6.2. Global Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anterior Cervical Discectomy And Fusion (ACDF)
  • Posterior Lumbar Interbody Fusion (PLIF)
  • Transforaminal Lumbar Interbody Fusion (TLIF)
  • Anterior Lumbar Interbody Fusion (ALIF)
  • Lateral Lumbar Interbody Fusion (LLIF)
  • Other Surgery Types
  • 6.3. Global Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Spinal Fusion
  • Spinal Non-Union And Fracture Repair
  • Degenerative Disc Disease Treatment
  • Other Applications
  • 6.4. Global Spine Biologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Spinal Surgery Centers
  • Orthopedic Clinics
  • Other End Users

7. Spine Biologics Market Regional And Country Analysis

  • 7.1. Global Spine Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Spine Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Spine Biologics Market

  • 8.1. Asia-Pacific Spine Biologics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Spine Biologics Market

  • 9.1. China Spine Biologics Market Overview
  • 9.2. China Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Spine Biologics Market

  • 10.1. India Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Spine Biologics Market

  • 11.1. Japan Spine Biologics Market Overview
  • 11.2. Japan Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Spine Biologics Market

  • 12.1. Australia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Spine Biologics Market

  • 13.1. Indonesia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Spine Biologics Market

  • 14.1. South Korea Spine Biologics Market Overview
  • 14.2. South Korea Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Spine Biologics Market

  • 15.1. Western Europe Spine Biologics Market Overview
  • 15.2. Western Europe Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Spine Biologics Market

  • 16.1. UK Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Spine Biologics Market

  • 17.1. Germany Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Spine Biologics Market

  • 18.1. France Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Spine Biologics Market

  • 19.1. Italy Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Spine Biologics Market

  • 20.1. Spain Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Spine Biologics Market

  • 21.1. Eastern Europe Spine Biologics Market Overview
  • 21.2. Eastern Europe Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Spine Biologics Market

  • 22.1. Russia Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Spine Biologics Market

  • 23.1. North America Spine Biologics Market Overview
  • 23.2. North America Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Spine Biologics Market

  • 24.1. USA Spine Biologics Market Overview
  • 24.2. USA Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Spine Biologics Market

  • 25.1. Canada Spine Biologics Market Overview
  • 25.2. Canada Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Spine Biologics Market

  • 26.1. South America Spine Biologics Market Overview
  • 26.2. South America Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Spine Biologics Market

  • 27.1. Brazil Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Spine Biologics Market

  • 28.1. Middle East Spine Biologics Market Overview
  • 28.2. Middle East Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Spine Biologics Market

  • 29.1. Africa Spine Biologics Market Overview
  • 29.2. Africa Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Spine Biologics Market Competitive Landscape And Company Profiles

  • 30.1. Spine Biologics Market Competitive Landscape
  • 30.2. Spine Biologics Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Stryker Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Baxter International Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. B. Braun Melsungen AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Spine Biologics Market Other Major And Innovative Companies

  • 31.1. Zimmer Biomet Holdings Inc.
  • 31.2. Arthrex Inc.
  • 31.3. Integra LifeSciences Corporation
  • 31.4. Bone Biologics Corp.
  • 31.5. InVivo Therapeutics Corp.
  • 31.6. RTI Surgical Inc.
  • 31.7. Paragon 28 Inc.
  • 31.8. LifeNet Health Inc.
  • 31.9. Xtant Medical Holdings Inc.
  • 31.10. Kuros Biosciences A.G.
  • 31.11. CoreLink LLC
  • 31.12. Spinal Elements Inc.
  • 31.13. Life Spine Inc.
  • 31.14. Innovasis Inc.
  • 31.15. Camber Spine Technologies LLC

32. Global Spine Biologics Market Competitive Benchmarking

33. Global Spine Biologics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Spine Biologics Market

35. Spine Biologics Market Future Outlook and Potential Analysis

  • 35.1 Spine Biologics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Spine Biologics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Spine Biologics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer